Stock listing
Dusseldorf:SRT Sartorius AG Aktie
German listing (Dusseldorf) of Sartorius AG · home listing Xetra:SRT
Follow Sartorius AG into a list and get an email when it puts out news.
Share price · DUS:SRT
€221.50 EUR -11.00 (-4.7%)
Close on Nov 20, 2026
- Day range
- €221.50 – €232.50 EURNov 20, 2026
- Market cap
- €39.76B EURAt the close on Nov 20, 2026 · price × 179.5M shares outstanding
- 52-week range
- €160.00 – €237.29 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €19 EURMedian day 0 shares · 56 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Xetra:SRT · Home | €224.00 EUR | -5.50 (-2.4%) | 3,832 | €232.00 | €234.00 | €224.00 | €229.50 | Close on Nov 20, 2026 |
| Xetra:SRT3 | €288.00 EUR | -11.00 (-3.7%) | 135,926 | €295.90 | €297.40 | €285.80 | €299.00 | Close on Nov 20, 2026 |
| Frankfurt:SRT | €232.50 EUR | -7.50 (-3.1%) | — | €232.50 | €232.50 | €232.50 | €240.00 | Close on Nov 20, 2026 |
| LSE:0NIQ | €224.50 EUR | -11.00 (-4.7%) | 58 | €229.50 | €234.00 | €224.00 | €235.50 | Close on Nov 20, 2026 |
| OTC:SUVPF | $323.09 USD | +13.63 (+4.4%) | 107 | $323.09 | $323.09 | $323.09 | $309.46 | Close on Nov 18, 2026 |
| Stuttgart:SRT3 | €285.10 EUR | -12.40 (-4.2%) | — | €297.50 | €297.50 | €285.10 | €297.50 | Close on Nov 20, 2026 |
| OTC:SOAGY | $62.35 USD | -3.80 (-5.7%) | 187 | $62.73 | $62.73 | $62.35 | $66.15 | Close on Nov 20, 2026 |
| Frankfurt:SRT3 | €285.50 EUR | -14.50 (-4.8%) | 40 | €295.90 | €295.90 | €285.50 | €300.00 | Close on Nov 20, 2026 |
| OTC:SSSGY | $43.93 USD | 0.00 (0.0%) | — | $43.93 | $43.93 | $43.93 | $43.93 | Close on Nov 6, 2026 |
| Stuttgart:SRT | €223.50 EUR | -2.50 (-1.1%) | — | €225.50 | €231.00 | €221.50 | €226.00 | Close on Nov 5, 2026 |
| Hamburg:SRT | €233.00 EUR | -1.50 (-0.6%) | — | €233.00 | €233.00 | €233.00 | €234.50 | Close on Nov 20, 2026 |
| Dusseldorf:SRT | €221.50 EUR | -11.00 (-4.7%) | — | €231.00 | €232.50 | €221.50 | €232.50 | Close on Nov 20, 2026 |
| Dusseldorf:SRT3 | €286.30 EUR | -11.00 (-3.7%) | — | €295.00 | €296.90 | €286.30 | €297.30 | Close on Nov 20, 2026 |
| Frankfurt:SRT0 | €57.50 EUR | -1.00 (-1.7%) | — | €57.50 | €57.50 | €57.50 | €58.50 | Close on Nov 20, 2026 |
| Frankfurt:SRT4 | €46.00 EUR | -0.60 (-1.3%) | — | €46.00 | €46.00 | €46.00 | €46.60 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · DUS:SRT · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €223.30 | -1.332 | -0.6% | €221.37 | €225.04 | €218.67 | 0 | |
| €224.63 | -1.748 | -0.8% | €225.51 | €228.98 | €224.24 | 0 | |
| €226.38 | +0.294 | +0.1% | €229.38 | €231.08 | €225.52 | 0 | |
| €226.08 | -5.985 | -2.6% | €227.87 | €228.00 | €225.01 | 0 | |
| €232.07 | +3.998 | +1.8% | €227.62 | €237.29 | €226.28 | 0 | |
| €228.07 | -4.326 | -1.9% | €231.29 | €234.81 | €227.97 | 0 | |
| €232.39 | +6.153 | +2.7% | €231.21 | €233.08 | €231.20 | 0 | |
| €226.24 | +2.962 | +1.3% | €225.10 | €230.65 | €223.23 | 0 | |
| €223.28 | +0.512 | +0.2% | €223.28 | €225.33 | €222.29 | 0 | |
| €222.77 | +2.502 | +1.1% | €222.78 | €222.78 | €218.06 | 0 | |
| €220.27 | +6.292 | +2.9% | €220.27 | €220.77 | €220.16 | 0 | |
| €213.97 | +5.556 | +2.7% | €209.55 | €214.00 | €207.88 | 0 | |
| €208.42 | +1.818 | +0.9% | €209.46 | €211.33 | €208.38 | 0 | |
| €206.60 | +2.021 | +1.0% | €206.51 | €206.65 | €206.47 | 0 | |
| €204.58 | +2.56 | +1.3% | €204.58 | €207.32 | €202.31 | 0 | |
| €202.02 | -3.594 | -1.7% | €205.94 | €206.71 | €201.40 | 0 | |
| €205.61 | +4.388 | +2.2% | €203.78 | €206.56 | €202.34 | 0 | |
| €201.22 | -0.089 | 0.0% | €200.96 | €207.08 | €199.97 | 0 | |
| €201.31 | -1.675 | -0.8% | €201.80 | €202.13 | €201.08 | 0 | |
| €202.99 | -0.688 | -0.3% | €203.02 | €204.10 | €202.79 | 0 | |
| €203.68 | +9.068 | +4.7% | €196.88 | €204.23 | €193.74 | 0 | |
| €194.61 | -11.71 | -5.7% | €204.30 | €205.31 | €194.03 | 0 | |
| €206.32 | +1.14 | +0.6% | €205.81 | €206.44 | €202.60 | 0 | |
| €205.18 | +4.161 | +2.1% | €203.37 | €212.53 | €201.24 | 0 | |
| €201.02 | +1.822 | +0.9% | €201.37 | €201.57 | €200.92 | 0 | |
| €199.19 | -0.791 | -0.4% | €198.87 | €199.43 | €198.51 | 0 | |
| €199.99 | -5.675 | -2.8% | €203.56 | €205.91 | €199.48 | 0 | |
| €205.66 | +2.069 | +1.0% | €205.66 | €209.00 | €205.28 | 0 | |
| €203.59 | -0.229 | -0.1% | €206.10 | €210.04 | €202.71 | 0 | |
| €203.82 | -1.966 | -1.0% | €204.32 | €208.52 | €203.20 | 0 | |
| €205.79 | -1.60 | -0.8% | €205.93 | €211.35 | €204.97 | 0 | |
| €207.39 | +4.321 | +2.1% | €204.31 | €207.56 | €203.86 | 0 | |
| €203.07 | +0.695 | +0.3% | €203.07 | €207.03 | €200.56 | 0 | |
| €202.37 | +5.855 | +3.0% | €196.73 | €203.47 | €196.57 | 0 | |
| €196.52 | +0.309 | +0.2% | €199.10 | €199.14 | €194.14 | 0 | |
| €196.21 | -0.048 | 0.0% | €195.96 | €200.97 | €195.52 | 0 | |
| €196.25 | +7.117 | +3.8% | €195.00 | €196.58 | €194.04 | 0 | |
| €189.14 | +0.086 | 0.0% | €189.54 | €192.01 | €189.09 | 0 | |
| €189.05 | +8.303 | +4.6% | €182.94 | €190.29 | €182.66 | 0 | |
| €180.75 | -1.739 | -1.0% | €182.97 | €183.26 | €179.53 | 0 | |
| €182.49 | -1.852 | -1.0% | €183.09 | €185.21 | €181.75 | 0 | |
| €184.34 | -0.409 | -0.2% | €185.71 | €185.85 | €182.94 | 0 | |
| €184.75 | -2.751 | -1.5% | €184.51 | €184.81 | €184.32 | 6 | |
| €187.50 | +3.465 | +1.9% | €186.89 | €188.63 | €186.73 | 0 | |
| €184.03 | -5.469 | -2.9% | €186.07 | €189.22 | €183.64 | 0 | |
| €189.50 | -4.736 | -2.4% | €193.79 | €194.76 | €189.47 | 0 | |
| €194.24 | +2.312 | +1.2% | €194.35 | €194.35 | €192.96 | 0 | |
| €191.93 | -2.113 | -1.1% | €192.76 | €195.28 | €190.42 | 0 | |
| €194.04 | -3.237 | -1.6% | €195.77 | €201.13 | €193.09 | 0 | |
| €197.28 | +0.278 | +0.1% | €198.76 | €200.76 | €197.12 | 0 | |
| €197.00 | +2.455 | +1.3% | €196.90 | €198.46 | €196.65 | 0 | |
| €194.54 | +1.739 | +0.9% | €193.49 | €195.64 | €193.40 | 0 | |
| €192.81 | +1.166 | +0.6% | €192.82 | €194.49 | €192.74 | 0 | |
| €191.64 | -1.352 | -0.7% | €191.64 | €192.35 | €189.15 | 0 | |
| €192.99 | -2.878 | -1.5% | €193.67 | €195.41 | €191.03 | 0 | |
| €195.87 | -0.386 | -0.2% | €196.01 | €196.01 | €194.42 | 0 | |
| €196.26 | +11.50 | +6.2% | €193.21 | €197.17 | €193.01 | 0 |
Splits
1 split · DUS:SRT · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 4-for-1 | Split |
- Ticker
- Dusseldorf:SRT
- Asset type
- Stock
- Exchange
- Dusseldorf
- Currency
- EUR
What changed lately
Latest news release · Jul 23, 2026
Sartorius maintains positive momentum and continues to grow profitably
Latest earnings call · Oct 22, 2026
Sartorius (Xetra:SRT) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Oct 22, 2026
9M 2026 Earnings Presentation
Earnings · 24 slides
Latest news
Sartorius maintains positive momentum and continues to grow profitably
Jul 23, 2026
Closed €178.66 (+1.0%) on Jul 23, 2026
Sartorius opens new competence center for cell and gene therapy components in Freiburg, Germany
May 21, 2026
Closed €185.99 (+2.5%) on May 21, 2026
Sartorius completes placement of bond with a volume of 500 million euros
May 6, 2026
Closed €177.05 (+0.5%) on May 7, 2026
Sartorius AG Supervisory Board extends appointment of board member Florian Funck
Apr 24, 2026
Closed €172.47 (+3.9%) on Apr 24, 2026
Sartorius marks positive start to 2026: Considerable sales revenue growth and resilient profit margin
Apr 23, 2026
Closed €165.97 (-9.5%) on Apr 23, 2026
Sartorius AG Supervisory Board Extends Appointment of Board Member Rene Faber
Mar 26, 2026
Closed €162.20 (-4.6%) on Mar 27, 2026
Sartorius sharpens strategy with biopharma focus and sets new mid-term growth targets
Mar 17, 2026
Closed €174.05 (+5.5%) on Mar 17, 2026
Sartorius Launches Next-generation Platform to Boost Efficiency in Cell Therapy Production
Mar 16, 2026
Closed €174.05 (+5.5%) on Mar 17, 2026
Sartorius Releases Annual Report for 2025
Feb 16, 2026
Closed €180.19 (+1.2%) on Feb 17, 2026
Sartorius Sharpens Climate Targets and Receives Validation from Science Based Targets Initiative
Feb 16, 2026
Closed €178.12 (-1.7%) on Feb 16, 2026
Sartorius AG on 6ix
- News releases
- 15 in the last 12 months · 18 in all · newest Jul 23, 2026 · oldest 2025
- Calls
- 13 calls with a replay · 13 with a transcript · latest Oct 22, 2026
- Decks
- 186 decks · latest Oct 22, 2026
Where Sartorius AG is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Xetra:SRT · Home listing | Xetra | Germany | EUR |
| Xetra:SRT3 | Xetra | Germany | EUR |
| gettex:SRT3 | gettex | Germany | EUR |
| gettex:SRT | gettex | Germany | EUR |
| Tradegate:SRT3 | Tradegate | Germany | EUR |
| Tradegate:SRT | Tradegate | Germany | EUR |
| LS Exchange:716563 | LS Exchange | Germany | EUR |
| Milan:1SRT | Milan | Italy | EUR |
| EUROTLX:4SRT | EUROTLX | Italy | EUR |
| Frankfurt:SRT | Frankfurt | Germany | EUR |
| OTC:SARTF | OTC | United States | USD |
| LS Exchange:716560 | LS Exchange | Germany | EUR |
| LSE:0NIQ | LSE | United Kingdom | EUR |
| LSIN:0NIR | LSIN | United Kingdom | EUR |
| Lang & Schwarz:716560 | Lang & Schwarz | Germany | EUR |
| Lang & Schwarz:716563 | Lang & Schwarz | Germany | EUR |
| VIE:SATG | Vienna | Austria | EUR |
| Aquis:SRT3D | Aquis | United Kingdom | EUR |
| OTC:SUVPF | OTC | United States | USD |
| Stuttgart:SRT3 | Stuttgart | Germany | EUR |
| OTC:SOAGY | OTC | United States | USD |
| Frankfurt:SRT3 | Frankfurt | Germany | EUR |
| Milan:1SRT3 | Milan | Italy | EUR |
| OTC:SSSGY | OTC | United States | USD |
| Stuttgart:SRT | Stuttgart | Germany | EUR |
| EUROTLX:4SRT3 | EUROTLX | Italy | EUR |
| Hanover:SRT | Hanover | Germany | EUR |
| Hamburg:SRT | Hamburg | Germany | EUR |
| Dusseldorf:SRT · This page | Dusseldorf | Germany | EUR |
| BSESOF:SRT3 | BSESOF | Bulgaria | EUR |
| Munich:SRT | Munich | Germany | EUR |
| SIX Swiss:SRT3 | SIX Swiss | Switzerland | CHF |
| Dusseldorf:SRT3 | Dusseldorf | Germany | EUR |
| Aquis:SRT3D | Aquis | United Kingdom | EUR |
| gettex:SRT0 | gettex | Germany | EUR |
| Hamburg:SRT3 | Hamburg | Germany | EUR |
| Hanover:SRT3 | Hanover | Germany | EUR |
| Munich:SRT3 | Munich | Germany | EUR |
| VIE:SRT3 | Vienna | Austria | EUR |
| Aquis:SRTD | Aquis | United Kingdom | EUR |
| BX Swiss:SRT | BX Swiss | Switzerland | CHF |
| gettex:SRT4 | gettex | Germany | EUR |
| Turquoise:SRT3D | Turquoise | United Kingdom | EUR |
| Aquis:SRTD | Aquis | United Kingdom | EUR |
| BX Swiss:SRT3 | BX Swiss | Switzerland | CHF |
| Dusseldorf:SRT0 | Dusseldorf | Germany | EUR |
| Dusseldorf:SRT4 | Dusseldorf | Germany | EUR |
| Frankfurt:SRT0 | Frankfurt | Germany | EUR |
| Frankfurt:SRT4 | Frankfurt | Germany | EUR |
| Munich:SRT0 | Munich | Germany | EUR |
| Munich:SRT4 | Munich | Germany | EUR |
| Turquoise:SRTD | Turquoise | United Kingdom | EUR |
Valuation
Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- €11.33B EUR
- P/E
- 35.1×
- EV/sales
- 3.1×
- EV/EBITDA
- 10.5×
- Price/book
- 2.6×
- Gross margin
- 45.4%
- Operating margin
- 17.8%
- Net margin
- 6.0%
- Debt to equity
- 1.3×
- Beta
- No index for this market yet
Forecasts
Analysts' consensus from EODHD, read Nov 15, 2026. Not 6ix's view and not investment advice.
- Price target
- 263.64 EUR · Analysts' mean
- EPS, year to Dec 2026
- 5.43 · 5 analysts
- Revenue, year to Dec 2026
- 3.74B · 21 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Michael Grosse | Chairman of the Executive Board | CEO |
| Florian Funck | Member of the Executive Board | CFO |
| Alexandra Gatzemeyer | Member of the Executive Board |
| René Fáber | Member of the Executive Board |
Board
| Director | Role |
|---|---|
| Lothar Kappich | Chairman of the Supervisory Board |
| Michael Grosse | Chairman of the Executive Board | CEO |
| Alexandra Gatzemeyer | Member of the Executive Board |
| Dietmar Müller | Vice Chairman of the Supervisory Board |
| Florian Funck | Member of the Executive Board | CFO |
| René Fáber | Member of the Executive Board |
Events
- Next results
- Feb 23, 2027 (expected)
Calls
| Call | When | Status |
|---|---|---|
| Sartorius (Xetra:SRT) Q3 2026 Earnings Call | Thu, Oct 22, 2026 · 7:00 AM ET | Replay |
| Sartorius (Xetra:SRT) Q2 2026 Earnings Call | Thu, Jul 23, 2026 · 7:00 AM ET | Replay |
| Sartorius (Xetra:SRT) Q1 2026 Earnings Call | Thu, Apr 23, 2026 · 7:00 AM ET | Replay |
| Sartorius (Xetra:SRT) Q4 2025 Earnings Call | Tue, Feb 03, 2026 · 7:00 AM ET | Replay |
| Sartorius (Xetra:SRT) Q3 2025 Earnings Call | Thu, Oct 16, 2025 · 7:00 AM ET | Replay |
| Sartorius (Xetra:SRT) Q2 2025 Earnings Call | Tue, Jul 22, 2025 · 7:00 AM ET | Replay |
| Sartorius (Xetra:SRT) Q1 2025 Earnings Call | Sat, Apr 26, 2025 · 7:00 AM ET | Replay |
| Sartorius (Xetra:SRT) Q4 2024 Earnings Call | Tue, Jan 28, 2025 · 7:00 AM ET | Replay |
| Sartorius (Xetra:SRT) Q3 2024 Earnings Call | Thu, Oct 17, 2024 · 7:00 AM ET | Replay |
| Sartorius (Xetra:SRT) Q1 2024 Earnings Call | Thu, Apr 18, 2024 · 7:00 AM ET | Replay |
All 13 calls
| Call | When | Status |
|---|---|---|
| Sartorius (Xetra:SRT) Q4 2023 Earnings Call | Fri, Jan 26, 2024 · 7:00 AM ET | Replay |
| Sartorius (Xetra:SRT) Q2 2023 Earnings Call | Fri, Jul 21, 2023 · 9:30 AM ET | Replay |
| Sartorius (Xetra:SRT) Q1 2023 Earnings Call | Thu, Apr 20, 2023 · 9:30 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Oct 21, 2026 · After close | +3.6% |
| Q2 2026 | Jul 22, 2026 · After close | −1.9% |
| Q1 2026 | Apr 22, 2026 · After close | −10.3% |
| Q4 2025 | Feb 3, 2026 · Before open | +6.0% |
| Q3 2025 | Oct 15, 2025 · After close | +7.5% |
| Q2 2025 | Jul 22, 2025 · Before open | −5.3% |
| Q1 2025 | Apr 15, 2025 · After close | +9.1% |
| Q4 2024 | Feb 16, 2025 · After close | −1.0% |
| Q3 2024 | Oct 17, 2024 · Before open | +16.8% |
| Q2 2024 | Jul 17, 2024 · After close | +0.2% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | Apr 17, 2024 · After close | −15.9% |
| Q4 2023 | Jan 25, 2024 · After close | +10.1% |
| Q3 2023 | Oct 19, 2023 · Before open | −0.2% |
| Q2 2023 | Jul 20, 2023 · After close | +6.4% |
| Q1 2023 | Apr 19, 2023 · After close | −11.3% |
| Q4 2022 | Jan 26, 2023 · Before open | +3.7% |
| Q3 2022 | Oct 19, 2022 · Before open | −16.6% |
| Q2 2022 | Jul 20, 2022 · After close | +8.1% |
| Q1 2022 | Apr 20, 2022 · After close | +1.4% |
| Q4 2021 | Feb 17, 2022 · Before open | −1.1% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| 9M 2026 Earnings Presentation | Earnings | 24 slides | Oct 22, 2026 |
| 9M 2026 Earnings Presentation | Earnings | 61 slides | October 2026 |
| H1 2026 Earnings Presentation | Earnings | 20 slides | Jul 23, 2026 |
| Sartorius Stedim Biotech — Investor Presentation (July 2026) | Investor deck | 47 slides | July 2026 |
| Investor Presentation (July 2026) | Investor deck | 61 slides | July 2026 |
| Q1 2026 Earnings Presentation | Earnings | 10 slides | Apr 23, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 20 slides | Apr 23, 2026 |
| Sartorius Stedim Biotech — Investor Day (March 2026) | Investor day | 34 slides | Mar 17, 2026 |
| Investor Day (March 2026) | Investor day | 39 slides | Mar 17, 2026 |
| FY2025 Earnings Presentation | Earnings | 13 slides | Feb 3, 2026 |
Show 50 decks
This page holds 50 of 186 decks. Open Decks
Financials
Annual, in EUR
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.54B | 3.38B | 3.40B | 4.17B | 3.45B | 2.34B | 1.83B | 1.57B | 1.40B | 1.30B |
| Cost of revenue | 1.90B | 1.86B | 1.83B | 1.98B | 1.61B | 1.13B | 885.8M | 762.4M | 697.7M | 668.5M |
| Gross profit | 1.64B | 1.52B | 1.57B | 2.20B | 1.84B | 1.21B | 941.2M | 803.6M | 706.8M | 631.8M |
| Research and development | 174.0M | 196.8M | 170.8M | 177.8M | 139.9M | 108.4M | 95.6M | 78.2M | 68.8M | 59.4M |
| Selling, general and administrative | 900.3M | 214.8M | 214.3M | 200.5M | 165.0M | 125.9M | 107.2M | 94.2M | 83.3M | 74.7M |
| Operating income | 651.4M | 437.2M | 543.2M | 1.14B | 735.8M | 523.5M | 355.9M | 300.6M | 263.0M | 247.7M |
| Depreciation and amortization | 420.1M | 415.9M | 341.6M | 287.1M | 231.2M | 180.6M | 132.6M | 113.4M | 98.4M | 75.7M |
| EBITDA | 1.07B | 853.1M | 884.8M | 1.42B | 967.0M | 704.1M | 488.5M | 414.0M | 361.3M | 323.4M |
| Interest expense | 198.0M | 205.4M | 156.9M | 67.9M | 45.5M | 57.4M | 27.8M | 25.1M | 26.7M | 17.4M |
| Income before tax | 337.0M | 186.8M | 385.9M | 1.18B | 668.4M | 446.7M | 303.2M | 270.7M | 198.6M | 204.1M |
| Income tax | 106.6M | 49.4M | 95.9M | 268.6M | 241.4M | 125.2M | 84.4M | 73.2M | 39.3M | 59.1M |
| Net income | 154.9M | 84.0M | 205.2M | 913.1M | 427.0M | 321.5M | 218.7M | 141.3M | 114.7M | 102.9M |
| Earnings per share, basic | 2.24 | 1.22 | 3.00 | 13.35 | 6.24 | 4.70 | 3.20 | 2.07 | 1.68 | 1.51 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 541.4M | 813.4M | 379.2M | 165.9M | 342.8M | 203.4M | 53.9M | 45.2M | 59.4M | 62.0M |
| Short-term investments | 10.4M | 15.3M | 15.0M | 30.9M | 18.2M | 14.2M | 12.0M | 22.2M | 15.3M | 10.0M |
| Receivables | 291.7M | 328.7M | 350.6M | 484.5M | 424.0M | 342.2M | 331.3M | 333.2M | 331.0M | 276.1M |
| Inventory | 792.2M | 788.5M | 1.04B | 1.18B | 874.1M | 551.7M | 408.5M | 318.3M | 241.7M | 217.5M |
| Current assets | 1.77B | 2.11B | 1.96B | 2.02B | 1.80B | 1.21B | 848.6M | 753.9M | 672.0M | 587.6M |
| Property, plant and equipment | 2.46B | 2.35B | 2.08B | 1.71B | 986.0M | 803.4M | 723.4M | 411.5M | 385.1M | 336.6M |
| Goodwill | 3.47B | 3.50B | 3.42B | 1.72B | 1.36B | 1.38B | 705.0M | 662.2M | 653.9M | 467.8M |
| Total assets | 9.72B | 10.1B | 9.76B | 6.98B | 5.70B | 4.70B | 2.84B | 2.53B | 2.30B | 1.75B |
| Accounts payable | 343.1M | 344.1M | 306.5M | 551.9M | 515.0M | 330.7M | 224.1M | 173.5M | 139.2M | 120.4M |
| Current liabilities | 1.97B | 1.44B | 1.33B | 1.80B | 1.55B | 870.9M | 661.6M | 480.7M | 393.7M | 364.4M |
| Long-term debt | 3.18B | 4.02B | 4.91B | 1.87B | 1.65B | 1.83B | 822.2M | 878.5M | 869.8M | 433.0M |
| Total debt | 4.45B | 4.56B | 5.31B | 2.54B | 2.08B | 2.09B | 1.07B | 1.00B | 999.2M | 611.4M |
| Total liabilities | 5.85B | 6.21B | 7.00B | 4.32B | 3.98B | 3.30B | 1.76B | 1.55B | 1.49B | 1.02B |
| Shareholders' equity | 2.71B | 2.76B | 2.07B | 1.99B | 1.26B | 1.05B | 810.4M | 740.6M | 617.8M | 579.7M |
| Shares outstanding | 69.0M | 69.0M | 68.4M | 68.4M | 68.4M | 68.4M | 68.4M | 68.4M | 68.4M | 68.4M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 656.0M | 976.2M | 853.6M | 734.2M | 865.8M | 511.5M | 377.2M | 244.5M | 206.5M | 170.4M |
| Capital spending | -441.9M | -409.9M | -559.7M | -522.6M | -407.2M | -240.3M | -225.6M | -233.2M | -197.1M | -148.8M |
| Free cash flow | 214.1M | 566.3M | 293.9M | 211.6M | 458.6M | 271.3M | 151.6M | 11.3M | 9.40M | 21.7M |
| Cash from investing | -513.5M | -425.8M | -2.82B | -1.13B | -569.6M | -1.27B | -268.7M | -242.5M | -555.1M | -268.2M |
| Cash from financing | -410.6M | -128.3M | 2.17B | 209.9M | -165.2M | 907.5M | -101.5M | -16.7M | 347.9M | 104.7M |
| Dividends paid | -50.7M | -50.7M | -98.2M | -85.9M | -48.2M | -24.3M | -42.1M | -34.5M | -31.1M | -34.5M |
| Share buybacks | 0 | 198.3M | ||||||||
| Change in cash | -272.0M | 434.2M | 213.3M | -176.9M | 139.4M | 149.0M | 8.75M | -14.3M | -2.60M | 9.23M |
Filings
Cap table
Built by 6ix from Sartorius AG’s releases
- Common shares
- 34,238,669
- Fully diluted
- 34,238,669
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 34,238,669 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 34,238,669 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Alexandra Gatzemeyer | Member of the Executive Board · Since at least Apr 24, 2026 |
| Dietmar Müller | Vice Chairman of the Supervisory Board · Since at least Nov 5, 2026 |
| Florian Funck | Member of the Executive Board | CFO · Since at least Apr 24, 2026 |
| Lothar Kappich | Chairman of the Supervisory Board · Since at least Nov 5, 2026 |
| Med-Tech Catalyst Robert Kline | Director · Oct 28, 2025 – Nov 5, 2026 · Past |
| Michael Grosse | Chairman of the Executive Board | CEO · Since at least Jul 23, 2026 |
| René Fáber | Member of the Executive Board · Since at least May 21, 2026 |
| Robert Kline | Director · Oct 28, 2025 – Nov 5, 2026 · Past |
Log in to ask 6ix AI your own questions about Sartorius AG.